ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,226.75
0.58%
Dow Jones
39,164.06
0.09%
Gold vs US Dollar
2,334.83
0.30%
Brent Oil
85.765
0.41%
Bitcoin
61,473.86
-0.22%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aziyo Biologics Inc (AZYO)

  7. Aziyo Biologics Inc (AZYO) News

Aziyo Biologics (AZYO)

Aziyo Biologics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AZYO
DateTimeSourceHeadlineSymbolCompany
22/04/202421:33Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AZYOAziyo Biologics Inc
22/04/202421:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AZYOAziyo Biologics Inc
01/04/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
08/09/202313:30GlobeNewswire Inc.Elutia to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AZYOAziyo Biologics Inc
07/09/202313:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
06/09/202321:05GlobeNewswire Inc.Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting BiomatricesNASDAQ:AZYOAziyo Biologics Inc
30/08/202313:30GlobeNewswire Inc.Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative ProceduresNASDAQ:AZYOAziyo Biologics Inc
14/08/202322:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AZYOAziyo Biologics Inc
14/08/202321:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
14/08/202321:05GlobeNewswire Inc.Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix CompanyNASDAQ:AZYOAziyo Biologics Inc
31/07/202321:05GlobeNewswire Inc.Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023NASDAQ:AZYOAziyo Biologics Inc
17/07/202321:05PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:AZYOAziyo Biologics Inc
13/07/202322:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
13/07/202321:30GlobeNewswire Inc.Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix ProductsNASDAQ:AZYOAziyo Biologics Inc
23/06/202316:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZYOAziyo Biologics Inc
12/06/202316:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZYOAziyo Biologics Inc
09/06/202321:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZYOAziyo Biologics Inc
19/05/202313:15GlobeNewswire Inc.Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic EnvelopeNASDAQ:AZYOAziyo Biologics Inc
12/05/202322:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AZYOAziyo Biologics Inc
10/05/202321:05GlobeNewswire Inc.Aziyo Biologics Reports Highest Sales and Gross Profit in Company HistoryNASDAQ:AZYOAziyo Biologics Inc
03/05/202321:05GlobeNewswire Inc.Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023NASDAQ:AZYOAziyo Biologics Inc
20/04/202321:30GlobeNewswire Inc.Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo’s Cardiovascular PortfolioNASDAQ:AZYOAziyo Biologics Inc
07/04/202311:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AZYOAziyo Biologics Inc
23/03/202321:10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AZYOAziyo Biologics Inc
22/03/202320:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZYOAziyo Biologics Inc
22/03/202320:01GlobeNewswire Inc.Aziyo Biologics Reports Record Full Year 2022 RevenuesNASDAQ:AZYOAziyo Biologics Inc
22/03/202312:30GlobeNewswire Inc.Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue ReconstructionNASDAQ:AZYOAziyo Biologics Inc
20/03/202321:27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZYOAziyo Biologics Inc
20/03/202312:00GlobeNewswire Inc.Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial EnvelopeNASDAQ:AZYOAziyo Biologics Inc
15/03/202320:05GlobeNewswire Inc.Aziyo Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 22, 2023NASDAQ:AZYOAziyo Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:AZYO

Your Recent History

BIT
I09512
XS2651529708 20270913 17...
TG
5NU
CapitaLand Investment
BIT
S28185
Societe Generale Effekten
BIT
P1V8M4
NLBNPIT1V8M4 20241220 22...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved